The effect of dapagliflozin treatment on epicardial adipose tissue volume

达帕格列嗪 医学 脂肪组织 内科学 糖尿病 冠状动脉疾病 糖尿 霍恩斯菲尔德秤 血管病学 内分泌学 减肥 心肌梗塞 心脏病学 胃肠病学 2型糖尿病 肥胖 外科 计算机断层摄影术
作者
Takao Sato,Yoshifusa Aizawa,Sho Yuasa,Shohei Kishi,Koichi Fuse,Satoshi Fujita,Yoshio Ikeda,Hitoshi Kitazawa,Minoru Takahashi,Masahito Sato,Masaaki Okabe
出处
期刊:Cardiovascular Diabetology [BioMed Central]
卷期号:17 (1): 6-6 被引量:417
标识
DOI:10.1186/s12933-017-0658-8
摘要

Glycosuria produced by sodium–glucose co-transporter-2 (SGLT-2) inhibitors is associated with weight loss. SGLT-2 inhibitors reportedly might reduce the occurrence of cardiovascular events. Epicardial adipose tissue (EAT) is a pathogenic fat depot that may be associated with coronary atherosclerosis. The present study evaluated the relationship between an SGLT-2 inhibitor (dapagliflozin) and EAT volume. In 40 diabetes mellitus patients with coronary artery disease (10 women and 30 men; mean age of all 40 patients was 67.2 ± 5.4 years), EAT volume was compared prospectively between the dapagliflozin treatment group (DG; n = 20) and conventional treatment group (CTG; n = 20) during a 6-month period. EAT was defined as any pixel that had computed tomography attenuation of − 150 to − 30 Hounsfield units within the pericardial sac. Metabolic parameters, including HbA1c, tumor necrotic factor-α (TNF-α), and plasminogen activator inhibitor-1 (PAI-1) levels, were measured at both baseline and 6-months thereafter. There were no significant differences at baseline of EAT volume and HbA1c, PAI-1, and TNF-α levels between the two treatment groups. After a 6-month follow-up, the change in HbA1c levels in the DG decreased significantly from 7.2 to 6.8%, while body weight decreased significantly in the DG compared with the CTG (− 2.9 ± 3.4 vs. 0.2 ± 2.4 kg, p = 0.01). At the 6-month follow-up, serum PAI-1 levels tended to decline in the DG. In addition, the change in the TNF-α level in the DG was significantly greater than that in the CTG (− 0.5 ± 0.7 vs. 0.03 ± 0.3 pg/ml, p = 0.03). Furthermore, EAT volume significantly decreased in the DG at the 6-month follow-up compared with the CTG (− 16.4 ± 8.3 vs. 4.7 ± 8.8 cm 3 , p = 0.01). Not only the changes in the EAT volume and body weight, but also those in the EAT volume and TNF-α level, showed significantly positive correlation. Treatment with dapagliflozin might improve systemic metabolic parameters and decrease the EAT volume in diabetes mellitus patients, possibly contributing to risk reduction in cardiovascular events.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
e00ec发布了新的文献求助10
1秒前
彭于晏的应助被12采纳,获得10
1秒前
fy完成签到,获得积分10
3秒前
ecauscibe完成签到,获得积分10
4秒前
秋秋发布了新的文献求助10
4秒前
诚心的志泽完成签到,获得积分10
4秒前
6秒前
6秒前
7秒前
ding的应助被zgm采纳,获得10
7秒前
Khalil完成签到,获得积分10
8秒前
10秒前
11秒前
13秒前
煜猪猪完成签到,获得积分10
13秒前
13秒前
necos发布了新的文献求助10
14秒前
chiaugustus发布了新的文献求助10
15秒前
yy完成签到,获得积分10
16秒前
隐隐完成签到,获得积分10
16秒前
zww发布了新的文献求助10
16秒前
17秒前
生尽证提发布了新的文献求助10
17秒前
17秒前
19秒前
核桃发布了新的文献求助10
20秒前
21秒前
lin完成签到,获得积分10
22秒前
德烁发布了新的文献求助10
22秒前
22秒前
22秒前
无极微光的应助被zxh_采纳,获得20
23秒前
23秒前
24秒前
25秒前
虚拟的觅山完成签到,获得积分10
25秒前
残忆思发布了新的文献求助30
26秒前
26秒前
chiaugustus完成签到,获得积分20
26秒前
所所的应助被竹蜻蜓采纳,获得10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192903
求助须知:如何正确求助?哪些是违规求助? 9579325
关于积分的说明 21864493
捐赠科研通 7792494
什么是DOI,文献DOI怎么找? 3437087
关于科研通互助平台的介绍 2560652
邀请新用户注册赠送积分活动 2483937